Stereoselective in vitro degradation pattern of mivacurium in human plasma

British Journal of Anaesthesia

Volumn 89, Issue 6, 2002, Pages 832-838

  Laurin, J ^a   Donati, F ^a   Varin, F ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Blood, plasma; Metabolism, mivacurium; Metabolism, stereoselective; Neuromuscular block, mivacurium

Indexed keywords

ALCOHOL; CHOLINESTERASE; MIVACURIUM;

ADULT; ARTICLE; BLOOD ANALYSIS; CIS ISOMER; CONTROLLED STUDY; DRUG DECOMPOSITION; DRUG DEGRADATION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HYDROLYSIS; DRUG STRUCTURE; ENZYME KINETICS; EXTRAVASCULAR SPACE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; ISOMER; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY; STEREOSPECIFICITY; TRANS ISOMER; VOLUNTEER;

EID: 0036903999     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aef270     Document Type: Article

References (13)

1. Belmont MR, Beemer G, Bownes P, Russo J, Wisowaty J, Savarese JJ. Comparative pharmacology of mivacurium and isomers in rhesus monkeys [abstract]. Anesth Analg 1993; 76: S18
2. Savarese JJ, Hassan HA, Salvatore JB, et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). Anesthesiology 1988; 68: 723-32
3. Lacroix M, Donati F, Varin F. Pharmacokinetics of mivacurium isomers and their metabolites in healthy volunteers after intravenous bolus administration. Anesthesiology 1997; 86: 322-30
4. Cook DR, Stiller RL, Weakly JN, Chakravorti S, Brandom BW, Welch RM. In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine. Anesth Analg 1989; 69: 452-6
5. Lien CA, Schmith VDE, Embree PB, Belmont MR, Wargin WA, Savarese JJ. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1994; 80: 1296-306
6. Wiesner G, Gruber M, Keyl C, Schneider A, Drescher J, Hobbhahn J. In vitro effects of fluoride on pseudocholinesterase activity and the metabolism of the cis-trans and trans-trans isomers of mivacurium. Anesthesiology 2001; 95: 806-7
7. Bryant BJ, James CD Jr, Cook DR, Harrelson JC. High performance liquid chromatography assay for cisatracurium and its metabolites in human urine. J Liquid Chromatogr Relat Technol 1997; 20: 2041-51
8. Fisher DM, Canfell PC, Fahey MR, et al. Elimination of atracurium in humans: Contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology 1986; 65: 6-12
9. Tran TV, Fiset P, Varin F. Pharmacokinetics and pharmacodynamics of cisatracurium after a short infusion in patients under propofol anesthesia. Anesth Analg 1998; 87: 1158-63
10. Bergeron L, Bevan DR, Berrill A, Kahwaji R, Varin F. Concentration-effect relationship of cisatracurium at three different dose levels in the anesthetized patient. Anesthesiology 2001; 95: 314-23
11. Ummenhofer WC, Brown SM, Bernards CM. Acetylcholinesterase and butyrylcholinesterase are expressed in the spinal meninges of monkeys and pigs. Anesthesiology 1998; 88: 1259-65
12. Ezzine S, Donati F, Varin F. Mivacurium arteriovenous gradient during steady state infusion in anesthetized patients. Anesthesiology 2002; 97: 622-9
13. Head-Rapson AG, Devlin JC, Parker CJR, Hunter JM. Pharmacokinetics and pharmacodynamics of the three isomers of mivacurium in health, in end-stage renal failure and in patients with impaired renal function. Br J Anaesth 1995; 75: 31-6